White Maple Pharmaceuticals Private Limited, a active private limited company, was established on 12 February 2016 in Dibrugarh, Assam, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230AS2016PTC012342. Registered under ROC Roc Guwahati. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.30 M.
It upholds a compliant status. Employing 23 professional, Its leadership includes Priteeshree Baruah (Director), Premananda Das (Director), Pabitra Kumar Baruah (Director). It holds ₹3.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Holding No.388, First Floor, Prp Enclave Jalan Nagar, Near Gm Hospital, Dibrugarh, Assam, 786005.
U24230AS2016PTC012342
012342
12 February 2016
₹1.00 M
₹0.30 M
Roc Guwahati
Unlisted
Active
Explore comprehensive insights into White Maple Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priteeshree Baruah | Director | 12 Feb 2016 | Current |
| Premananda Das | Director | 12 Feb 2016 | Current |
| Pabitra Kumar Baruah | Director | 12 Feb 2016 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
White Maple Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 44.36% increase. The company also saw a slight improvement in profitability, with a 8.06% increase in profit. The company's net worth Soared by an impressive increase of 44.59%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, White Maple Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Feb 2020 | Syndicate Bank | ₹3.00 M | Open |
Explore comprehensive loan charge details -
White Maple Pharmaceuticals has a workforce of 23 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of White Maple Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped White Maple Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on White Maple Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
White Maple Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Guwahati. was recorded as a recent event.
Progress on A charge with Syndicate Bank amounted to Rs. 3.00 M with Charge ID 100327969 was registered on 25 Feb 2020. was documented.
The activity Priteeshree Baruah was appointed as a Director was appointed as a Director on 12 Feb 2016 & has been associated with this company since 9 years 10 months . was completed.
The activity Premananda Das was appointed as a Director was appointed as a Director on 12 Feb 2016 & has been associated with this company since 9 years 10 months . was completed.
Pabitra Kumar Baruah was appointed as a Director was appointed as a Director on 12 Feb 2016 & has been associated with this company since 9 years 10 months . was recorded as a recent event.
The CIN of White Maple Pharmaceuticals Private Limited is U24230AS2016PTC012342.
White Maple Pharmaceuticals Private Limited is headquartered at Holding No.388, First Floor, Prp Enclave Jalan Nagar, Near Gm Hospital, Dibrugarh, Assam, 786005.
White Maple Pharmaceuticals Private Limited was incorporated on 12 February 2016.
The current directors of White Maple Pharmaceuticals Private Limited are
The primary industry of White Maple Pharmaceuticals Private Limited is Trade.
White Maple Pharmaceuticals Private Limited is unlisted.
The authorized capital of White Maple Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.30 M.
The compliance status of White Maple Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX